Jane Street Group, LLC Bridge Bio Pharma, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 717,185 shares of BBIO stock, worth $18.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

717,185

Previous 229,576 212.4%

Holding current value

$18.6 Million

Previous $7.1 Million 155.93%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $11.2 Million - $15.1 Million	487,609 Added 212.4%	717,185 $18.2 Million
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $187,456 - $277,244	-6,854 Reduced 2.9%	229,576 $7.1 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $1.94 Million - $3.55 Million	-80,852 Reduced 25.48%	236,430 $9.54 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $462,988 - $959,694	-27,412 Reduced 7.95%	317,282 $8.37 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $2.45 Million - $3.33 Million	184,682 Added 115.42%	344,694 $5.93 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $759,690 - $1.97 Million	105,954 Added 196.0%	160,012 $2.65 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $228,371 - $390,332	33,883 Added 167.95%	54,058 $411,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $479,361 - $746,210	-60,373 Reduced 74.95%	20,175 $201,000
Q2 2022 Aug 16, 2022	BUY	$5.21 - $12.14 $302,471 - $704,799	58,056 Added 258.12%	80,548 $731,000
Q1 2022 May 17, 2022	SELL	$7.34 - $17.16 $1.1 Million - $2.57 Million	-149,845 Reduced 86.95%	22,492 $228,000
Q4 2021 Feb 15, 2022	BUY	$11.38 - $53.41 $1.52 Million - $7.11 Million	133,197 Added 340.31%	172,337 $2.87 Million
Q3 2021 Nov 16, 2021	BUY	$46.87 - $64.24 $1.33 Million - $1.82 Million	28,278 Added 260.34%	39,140 $1.83 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $95,263 - $131,056	2,050 Added 23.26%	10,862 $662,000
Q1 2021 May 18, 2021	SELL	$55.47 - $72.35 $2.02 Million - $2.64 Million	-36,478 Reduced 80.54%	8,812 $543,000
Q4 2020 Feb 17, 2021	BUY	$38.38 - $71.11 $587,482 - $1.09 Million	15,307 Added 51.05%	45,290 $3.22 Million
Q3 2020 Nov 17, 2020	BUY	$27.2 - $42.19 $557,763 - $865,148	20,506 Added 216.38%	29,983 $1.13 Million
Q2 2020 Aug 17, 2020	BUY	$22.22 - $35.69 $210,578 - $338,234	9,477 New	9,477 $309,000

Others Institutions Holding BBIO

# of Institutions

294

Shares Held

177M

Call Options Held

8.72M

Put Options Held

2.75M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Bridge Bio Pharma, Inc. Transaction History